egfr-tki therapy in advanced nsclc
Published 6 years ago • 336 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
2:26
additional egfr-tki therapy research in nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
20:24
targeted treatment with egfr tkis: front line options
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
4:38
egfr tkis as adjuvant therapy in nsclc
-
1:05
dr. sequist on frontline egfr tki use in nsclc
-
4:23
evolution of targeted therapy in advanced nsclc
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
0:50
treating patients with egfr-mutant lung cancer with targeted therapies
-
2:20
osimertinib in advanced non–small-cell lung cancer
-
3:14
advancements of targeted therapy for egfr mutations in nsclc
-
1:14
evaluating the role of egfr mutations in the treatment of advanced nsclc
-
2:04
jack west, md: use of tki therapy in patients with egrf exon 19 deletion nsclc
-
59:19
precision oncology in early-stage lung cancer, with adjuvant egfr-targeted therapy leading the way
-
5:10
sequencing egfr-targeted therapies in nsclc
-
1:33
neoadjuvant egfr tki trials in nsclc
-
2:51
early results from a 3rd gen egfr-tki in advanced nsclc
-
2:02
dr. goldberg discusses resistance to egfr tki therapy in nsclc
-
1:24
egfr tkis excite treatment landscape of egfr-mutant lung cancers